Asks the fella who magically managed to sell ALL his shares for dramatic effect .... three times. |
Any of you made money from this donkey pmsl |
And where is ANY, and by that I mean just one, piece of solid evidence that they are remunerated please?
You know they will never respond to you as you are mute on their account? Or are you that stupid… |
Alchemy 21 Jan '25 - 18:56 - 19769
> So we’re just as pleased with sells as with buys.
> How long to go before each of my accumulation pounds buys fewer shares ?
We already know "god" handed out brains to the likes of Timbo_Slice in the night time... so they may have got to the wrong part of the anatomy.
However, improbable as it may appear, you may actually be STUPIDER.
:D ROTFL |
 Sean Hackett Money flow commodity report; Commentary by S Hunt
Right now the Atlantic Ocean has been in the 40-year warming cycle phase
that has been primary responsible for warming the planet over the last 40 years ..
that cycle Ends by 2025 and will usher in a 40-year
Atlantic cooling cycle phase that will reverse the current warming
effects ..what bothers us is that the last time the Atlantic Cycle turned cold was
1965 and the impact to cooling the planet was severe and caused accentuated
weather volatility shorter growing Cycles later spring frosts and earlier
fall frosts that played Havoc with food production
we did not have a quiet sun and back then we do now and that means that both the
sun and the Atlantic Ocean will be pushing a colder climate Trend
simultaneously for the first time since the early 1600s we also have the Yoshimura
planetary temperature 60-year cycle and the big Galesburg planetary temperature 84 year
cycle causing additional weather spikes troughs as in the
1930s the synchronicity of all these Cycles was last seen at the beginning of the 1600s. |
Regarding Ecovelex;
@27.38m
19 Jan 2025
"and through a number of discussions with partners and potential Partners we identified that there was an opportunity to protect seeds from bird damage"
.............................
@3.40 'Collaboration with Corteva' |
Thanks Investing. I have seen these numbers and heard the share price targets from the mgt team. I absolutely see the potential here, and agree powdery and Downey mildew, Ecovelex and insecticide are all likely to substantially improve Edens fortunes over time. Hopefully the USA will also start to show some meaningful progress. All of this is undoubtedly coming…
For me, the question remains over how much ‘time’ for all of this to materialise. It’s is still taking too much time and thereforethe worry becomes short term funding. I have every confidence it will get there.. but cavindish have put a forecast of 20p on Eden for at least 2 years, and we are no where close. Sean and Alex’s predictions of far higher, although exciting, is nothing more than pipe dreams until we all start to see meaningful growth in the share price (I understand, as I’m sure you do why the share price is hanging around at current levels).
Again, not trying to be a nay sayer or negative. Just realistic. Multiple years of revenue and sales growing YoY and the new products will only accelerate that… but when…. And more importantly when will be see consistent and meaningful share price growth. Then and only then, will enthusiasm for Eden be maintained. |
So we're just as pleased with sells as with buys. How long to go before each of my accumulation pounds buys fewer shares ? |
KittyBiscuits
If you look at the following presentation
you will see Eden's current and future product sales forecast. Eden states this is *Based on peak sales and a full label of all key target diseases and crops
Fair enough, but these forecasts far exceed anything Cavendish has published. How much attention are investors paying to this presentation? Does it need to be spoken to an audience so that it sinks in?
From the presentation
CURRENT (€M)
Mevalone 2.8
Cedroz 8.2 inc US
Ecovelex 3.6
to which you can hopefully, shortly, add another 14.4 with Downy Mildew and the insecticide
If you add up the current and future opportunity, I believe you get to a figure of around €130+ million
You have to assume we are pretty well advanced with Mevalone and Cedroz and their label extensions and regulatory approvals, accepting there is always more to come
The Company has said EU wide approval of Ecovelex will come this year
The Company has said Downy Mildew France, will come this year.
That just leaves the insecticide and whether the Company has submitted regulatory papers in the EU and the US. This we do not know. Might we be waiting for this prior to appointing a commercial partner(s). Who knows.
These numbers far exceed the current turnover of £4.3 million and perhaps it would be helpful to talk to a wide audience about this value opportunity, in laymans terms, such that the value proposition is understood by everyone.
Currently, Cavendish says Eden's target price is 20p. This is purely based on a 1 year forecast of regulatory approved products and anticipated sales, is it not?
The Company has said on film that in their opinion, managements opinions, the shares are already worth more than this.
Allowing for the published product sales on the Interims, available for all to see, conditional on regulatory approvals and label extensions, what is managements view of what the share price would look like, would be fairly valued at, in the event of this sales outcome.
Values are published, so it is not unreasonable for them to paint the same picture for the share price, after all, they have already commented on the same.
Some inspiration and belief for investors is perhaps one of the things needed to get the share price moving. Of course, removing a big seller (BGF) and a nice DM France regulatory approval would help and enhance this messaging. |
In this flopisode of The Sunday salad.
Sean Smith, CEO of Eden Research, delves into their innovative biopesticides and how these products are shaping sustainable agriculture along with roasty questions like why are you and your CFO paid so much and own so few company shares. Alongside these insightful interviews, the team delivers their usual roundup of the week’s biggest news stories, market movers, and the lively stock market banter you’ve come to expect. |
Breaking ground in biologicals: Major agricultural companies' brand strategies and market evolution,
"Our real point of differentiation is our passion for innovation. This combination of research-driven innovation and deep market understanding is what sets us apart from most biologicals players.″ said Matt Pickard, Head of Biologicals & Seedcare Europe at Syngenta, in an interview with AgroPages.
From 2019 to 2024, companies such as Gowan, Sumitomo Chemical, Nufarm, and Syngenta have actively expanded their biological businesses and launched new products on a global scale. Whether through technological innovation, market integration, or cross-sector cooperation and resource integration, biologicals have evolved from innovative solutions to a vital component of agricultural production.
In particular, 2023 and 2024 saw a surge in new biological brand launches by major agrochemical companies, driven by the promotion of green agriculture and environmental protection policies. This shift highlights the growing potential of biological solutions in the agricultural sector. It not only underscores the increasing importance of biologicals as a key industry development trend, but also reflects a significant rise in global market demand. In response, companies are moving beyond market segments to embrace full-chain strategies, fostering more comprehensive and diversified business growth. |
I like so many features here.Geographically spread even though U.K. has scored an own goal of huge scale.Regulation approvals have a ratchet effect. Customers - Farmers evaluate the product fully and inspect and measure full results.Nothing to do with war.Nothing to do with US Politics.Very little recognition yet.Pipeline ..., I always react badly to exhortations to patience but in effect I'm showing it.Breakeven at 8 million?Did I dream it or did someone say turnover at £100 million in 5 years. That's to say a route can be shown to such a figure. |
I like so many features here.Geographically spread even though U.K. has scored an own goal of huge scale.Regulation approvals have a ratchet effect. Customers - Farmers evaluate the product fully and inspect and measure full results.Nothing to do with war.Nothing to do with US Politics.Very little recognition yet.Pipeline ..., I always react badly to exhortations to patience but in effect I'm showing it.Breakeven at 8 million?Did I dream it or did someone say turnover at £100 million in 5 years. |
Yeah, yeah. Perhaps you should listen to the video Super posted. Some good soundbites from Sean.
Ecovelux approval is coming.
Insecticide is coming and a long list of other opportunities to work through.
Your doom and gloom outlook will soon enough be blown out of the water. |
And what crimes have I committed? List them please?
And I have told you before, I will not stand in front of a judge for anything related to Eden. When the penny finally drops, and you understand - let me know. |
I found that interview interesting . Some insights into farmer reaction and I thought I detected some strains of inevitability or SoIs lol Atb |
Kittybiscuit's feigned ignorance of his own crimes committed in RL is further exacerbation. But it is unnecessary. The extent, complexity and duration of the misconduct already merits the maximum sentence prescribed in the guidelines.
Start attending Crown Court as an observer. Prepare thyself for what awaits.
Should the offence of stupidity be added to the statute book? |
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Hot Features
Premium
